A

AVM Biotechnology

14 employees

AVM Biotechnology is a clinical stage company.

Basic info

Industry

biotechnology research

Sectors

Autoimmunity
Biotechnology
Personalized Medicine
Pharmaceutical
Regenerative Medicine
Drug Discovery
Stem Cells
R&D
Immunology
Fully Human Biologics
Medical
Diabetes
Cancer

Date founded

2008

Funding rounds raised

Total raised

$2M

from 2 investors over 2 rounds

A

AVM Biotechnology raised $2M on June 14, 2022

Investors: National Institutes of Health

A

AVM Biotechnology raised $1.6M on April 5, 2022

Investors: NIDDK, NIH

FAQ